NASDAQ:ABIO

ARCA biopharma - ABIO Stock Forecast, Price & News

$2.17

-0.03 (-1.36%)

(As of 02/8/2023 12:00 AM ET)

Add

Compare

Today's Range: $2.17
▼
$2.22
50-Day Range: $2.07
▼
$2.55
52-Week Range: $1.76
▼
$2.70

Volume: 26,089 shs
Average Volume: 32,796 shs
Market Capitalization: $31.27 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

About ARCA biopharma (NASDAQ:ABIO) Stock

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Stock News Headlines

February 6, 2023 | americanbankingnews.com

ARCA biopharma (NASDAQ:ABIO) Now Covered by StockNews.com

January 11, 2023 | foxnews.com

Frankie Muniz to race in ARCA Menards Series

February 9, 2023 | Vector Vest (Ad)

Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation

Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.

January 11, 2023 | benzinga.com

FRANKIE MUNIZ TAKES ON 2023 ARCA MENARDS SERIES CHAMPIONSHIP IN RETTE JONES RACING NO. 30 FORD MUSTANG

January 9, 2023 | msn.com

‘Goya, Carrière and the Ghost of Buñuel’ Wins Uruguay’s ARCA

January 2, 2023 | msn.com

Featuring ‘Caravaggio,’ ‘Charlotte,’ ‘Dreaming Walls,’ Uruguay’s ARCA Kicks Off Second Edition

December 19, 2022 | finance.yahoo.com

James Flynn Joins ARCA biopharma Board of Directors

November 14, 2022 | finance.yahoo.com

One ARCA biopharma, Inc. (NASDAQ:ABIO) insider upped their stake by 5,155% in the previous year

February 9, 2023 | Vantage Point (Ad)

Don’t Let The Markets Break Your Heart

Every rose has its thorn, just like every market has its surprise. If you’re having issues in your trading, it could be that it's not you - it really is the market… Well, you’re in control. You can sit on the sideline when it feels right, or anticipate massive trend reversals with A.I.

October 29, 2022 | finanznachrichten.de

ARCA biopharma, Inc.: ARCA biopharma Announces Third Quarter 2022 Financial Results

October 28, 2022 | finance.yahoo.com

ARCA biopharma Announces Third Quarter 2022 Financial Results

October 13, 2022 | msn.com

Mother, daughter set to compete in ARCA West race in Las Vegas

October 9, 2022 | foxnews.com

ARCA race ends with tempers flaring between Sammy Smith, Jesse Love

October 7, 2022 | msn.com

How to Watch NASCAR, Formula 1, ARCA and Everything Else in Racing This Weekend, October 8-9

September 20, 2022 | seekingalpha.com

ABIO ARCA biopharma, Inc.

September 15, 2022 | foxnews.com

ARCA driver Toni Breidinger becomes Victoria's Secret model: 'Little me is crying'

September 14, 2022 | msn.com

NASCAR returns to Milwaukee Mile with Craftsman Truck and ARCA series

September 11, 2022 | msn.com

Corey Heim bows out of ARCA series with Kansas Speedway win

September 4, 2022 | msn.com

Du Quoin State Fair ARCA Menards Series event postponed due to wet conditions

August 26, 2022 | tmcnet.com

SESAMI WELCOMES GLOBAL LEADER ARCA AS IT STRENGTHENS ITS GLOBAL LEADERSHIP IN CASH AUTOMATION SOLUTIONS

August 18, 2022 | msn.com

How to watch Watkins Glen ARCA Menards race: Time, TV channel, free live stream

August 2, 2022 | finance.yahoo.com

ARCA biopharma Announces Second Quarter 2022 Financial Results

July 22, 2022 | msn.com

Pocono Raceway cancels Friday ARCA events due to severe weather

July 18, 2022 | finance.yahoo.com

Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Deliver On Growth Plans?

July 5, 2022 | benzinga.com

ARCA Recycling, a Subsidiary of JanOne Inc., Unveils New Logo and Website

June 21, 2022 | benzinga.com

Jacob Ma-Weaver Joins ARCA biopharma Board of Directors

May 5, 2022 | finance.yahoo.com

ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Company Calendar

Last Earnings: 8/04/2021
Today: 2/09/2023
Next Earnings (Estimated): 3/13/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostic substances
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ABIO
CUSIP: N/A
CIK: 907654
Web: arcabio.com
Phone: (720) 940-2200
Fax: 720-208-9261
Employees: 17
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-19,320,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -30.92%
Return on Assets: -29.00%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 23.00
Quick Ratio: 23.00

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.54 per share
Price / Book: 0.61

Miscellaneous

Outstanding Shares: 14,410,000
Free Float: 11,485,000
Market Cap: $31.27 million
Optionable: Not Optionable
Beta: 1.60

Key Executives

Michael R. Bristow
President, Chief Executive Officer & Director

Thomas A. Keuer
Chief Operating Officer

C. Jeffrey Dekker
Chief Financial Officer

Debra Marshall
Chief Medical Officer

Christopher David Ozeroff
Secretary, Senior Vice President & General Counsel

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ABIO Stock - Frequently Asked Questions

How have ABIO shares performed in 2023?: ARCA biopharma's stock was trading at $2.37 on January 1st, 2023. Since then, ABIO shares have decreased by 8.4% and is now trading at $2.17.
View the best growth stocks for 2023 here.
Are investors shorting ARCA biopharma?: ARCA biopharma saw a drop in short interest in the month of January. As of January 15th, there was short interest totaling 284,300 shares, a drop of 51.1% from the December 31st total of 581,500 shares. Based on an average daily volume of 38,200 shares, the days-to-cover ratio is currently 7.4 days. Approximately 2.0% of the company's shares are short sold.
View ARCA biopharma's Short Interest.
When is ARCA biopharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, March 13th 2023.
View our ABIO earnings forecast.
How were ARCA biopharma's earnings last quarter?: ARCA biopharma, Inc. (NASDAQ:ABIO) issued its quarterly earnings results on Wednesday, August, 4th. The biopharmaceutical company reported ($0.34) EPS for the quarter, topping the consensus estimate of ($2.37) by $2.03.
What is Michael R. Bristow's approval rating as ARCA biopharma's CEO?: 1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ARCA biopharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).
What is ARCA biopharma's stock symbol?: ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO."
Who are ARCA biopharma's major shareholders?: ARCA biopharma's stock is owned by a number of retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Christopher David Ozeroff, Fund Lp Funicular and Robert E Conway.
View institutional ownership trends.
How do I buy shares of ARCA biopharma?: Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ARCA biopharma's stock price today?: One share of ABIO stock can currently be purchased for approximately $2.17.
How much money does ARCA biopharma make?: ARCA biopharma (NASDAQ:ABIO) has a market capitalization of $31.27 million. The biopharmaceutical company earns $-19,320,000.00 in net income (profit) each year or ($1.01) on an earnings per share basis.
How can I contact ARCA biopharma?: ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The official website for the company is arcabio.com. The biopharmaceutical company can be reached via phone at (720) 940-2200, via email at derek.cole@arcabio.com, or via fax at 720-208-9261.

This page (NASDAQ:ABIO) was last updated on 2/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial